Research
Development and validation of a clinical nomogram for predicting sarcopenia risk in elderly patients with chronic heart failure
Nature ·
The Brief
- A study describes developing and validating a clinical nomogram to predict sarcopenia risk.
- The population studied is elderly patients with chronic heart failure.
- The source provided only the title, so the model's inputs, performance and sample size are not described here.
Why it matters
Sarcopenia, or loss of muscle mass and strength, is a common complication in older people with chronic heart failure. A validated risk tool could help clinicians identify high-risk patients earlier.
Who’s affected
- cardiologists and geriatricians
- clinical researchers working on heart failure and muscle loss
- #heart failure
- #sarcopenia
- #nomogram
- #geriatrics
- #clinical prediction